Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Summary

Inari Medical, Inc. (NASDAQ: NARI), a leading medical device company, will participate virtually in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 14, 2023. The company is dedicated to transforming patient care through innovative solutions for venous diseases and beyond. Inari’s ethos emphasizes patient-focused principles and a commitment to improving lives. They strive to establish their treatments as the standard of care for venous thromboembolism. For inquiries, investors can contact Caroline Corner at ICR Westwicke.

News Market Reaction – NARI

+0.60%

+0.60% Session move

In the trading session that priced this news, NARI gained 0.60%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

IRVINE, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will participate virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 14, 2023.

About Inari Medical, Inc.
Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underrecognized health needs. In addition to our purpose-built products, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous thromboembolism and beyond. We are just getting started.

Investor Contact:
ICR Westwicke
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com

FAQ

What conference will Inari Medical (NARI) participate in?

Inari Medical will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 14, 2023.

What is the mission of Inari Medical (NARI)?

Inari Medical aims to treat and transform the lives of patients suffering from venous diseases and other health needs.

How does Inari Medical (NARI) improve patient outcomes?

Inari Medical improves patient outcomes through innovative solutions, education, clinical research, and program development.

Who can investors contact for more information about Inari Medical (NARI)?

Investors can contact Caroline Corner at ICR Westwicke for more information.

What is Inari Medical's focus in healthcare?

Inari Medical focuses on establishing their treatments as the standard of care for venous thromboembolism and other related conditions.